產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-ADCY3抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ADCY3抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ADCY3
Cat. Number:
Anti-ADCY3抗體XY-4021R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The cAMP synthesizing enzymes are found in two forms: cytosolic (soluble) and membrane-bound (particulate). Stimulation of adenylate cyclases produce cAMP form ATP in response to the activation of GPCRs by various hormones, neurotransmitters and other regulatory molecules. cAMP, in subsequent steps down the signal transduction pathway, can stimulate cAMP-dependent protein kinase A (cPKA), and several other target molecules. Activation of cPKA can phosphorylate a broad range of substrates Anti-ADCY3抗體that regulate various metabolic pathways, gene expression, and affect memory functions etc. The stimulation of adenylate cyclases starts with interactions with GPCRs mediated signals initiated by Gs and Gi heterotrimeric G-proteins.
Also known as:
A cyclase III; Anti-ADCY3抗體AC3; adenylate cyclase 3; Adenylate cyclase type III; ADCY3_HUMAN; Adenylate cyclase type 3; ATP pyrophosphate-lyase 3; AC-III; Adenylate cyclase, olfactive type; AC3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ADCY3。.
●
Predicted Molecular Weight: 126kDa.
Storage:
Shipped at 4℃, Anti-ADCY3抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Anti-ADCY3抗體Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Anti-ADCY3抗體Optimal working dilutions must be determined by the end user.
xy-13359R phospho-GIRK1 (Ser185)磷酸化G蛋白激活內(nèi)向鉀通道1抗體
xy-13360R GIT2G蛋白偶聯(lián)受體激酶相互作用蛋白2抗體
xy-13362R GJA10間隙連接蛋白10抗體
xy-13363R GJA3間隙連結(jié)蛋白46/白內(nèi)障相關(guān)蛋白抗體
xy-13364R GJA8間隙連結(jié)蛋白50/白內(nèi)障相關(guān)蛋白抗體
xy-13365R GJC1間隙連結(jié)蛋白31.9抗體
xy-13366R GK2甘油激酶2抗體
xy-13369R GLB1β-半乳糖苷酶1/β-Gal/彈性蛋白受體1抗體
xy-13370R GLDC甘氨酸脫羧酶P蛋白抗體
xy-13371R GLE1核孔蛋白GLE1抗體
xy-13372R GLEPP1腎小球上皮蛋白1抗體
xy-13373R GLI4轉(zhuǎn)錄因子Gli4/鋅指蛋白gli4抗體
xy-13374R Gliadin麥角蛋白抗體
xy-13375R GLIPR1L1膠質(zhì)瘤發(fā)病相關(guān)蛋白1抗體
xy-13378R GLT25D1糖基轉(zhuǎn)移酶25結(jié)構(gòu)域1/前膠原半乳糖基轉(zhuǎn)移酶1抗體
xy-13376R GLS2谷氨酰胺酰胺水解酶抗體
xy-13379R GLT25D2糖基轉(zhuǎn)移酶25結(jié)構(gòu)域2/前膠原半乳糖基轉(zhuǎn)移酶2抗體
xy-13380R GLT28D1糖基轉(zhuǎn)移酶28家族1抗體
xy-13381R GLT6D1糖基轉(zhuǎn)移酶6結(jié)構(gòu)1抗體
xy-13382R GLTSCR2膠質(zhì)瘤抑癌候選基因2抗體
xy-13384R Phospho-Glucocorticoid Receptor (Ser226)磷酸化糖皮質(zhì)**受體抗體
xy-13388R GLUT6葡萄糖轉(zhuǎn)運(yùn)蛋白6抗體
